Gal Cafri

1.5k total citations · 1 hit paper
17 papers, 786 citations indexed

About

Gal Cafri is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gal Cafri has authored 17 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Gal Cafri's work include Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Gal Cafri is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Gal Cafri collaborates with scholars based in Israel, United States and Germany. Gal Cafri's co-authors include Steven A. Rosenberg, Paul F. Robbins, Jared J. Gartner, Rami Yossef, Maria R. Parkhurst, Todd D. Prickett, Mohammad Jafferji, Anna Pasetto, Biman C. Paria and Tal Zaks and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Gal Cafri

17 papers receiving 763 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

2020 313 citations Gal Cafri, Jared J. Gartner et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gal Cafri Israel	12	566	517	336	90	81	17	786
Dirk M. van der Steen Netherlands	14	432 0.8×	440 0.9×	283 0.8×	145 1.6×	49 0.6×	28	747
Marten Visser Netherlands	10	867 1.5×	869 1.7×	303 0.9×	60 0.7×	77 1.0×	15	1.1k
Xuexiang Du United States	10	504 0.9×	586 1.1×	204 0.6×	96 1.1×	51 0.6×	21	856
Samuel Alsén Sweden	9	513 0.9×	277 0.5×	191 0.6×	56 0.6×	31 0.4×	15	737
Erika J. Crosby United States	13	314 0.6×	256 0.5×	161 0.5×	57 0.6×	74 0.9×	24	573
Anthony Miliotto United States	13	570 1.0×	559 1.1×	255 0.8×	81 0.9×	37 0.5×	23	866
Elien M. Doorduijn Netherlands	10	663 1.2×	496 1.0×	222 0.7×	51 0.6×	31 0.4×	12	867
Dries Renmans Belgium	8	296 0.5×	244 0.5×	253 0.8×	60 0.7×	70 0.9×	9	500
William R. Gwin United States	13	295 0.5×	426 0.8×	272 0.8×	59 0.7×	125 1.5×	34	669
Ralph Venhaus United States	14	555 1.0×	443 0.9×	302 0.9×	84 0.9×	44 0.5×	44	888

Countries citing papers authored by Gal Cafri

Since Specialization

Citations

This map shows the geographic impact of Gal Cafri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Cafri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Cafri more than expected).

Fields of papers citing papers by Gal Cafri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Cafri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Cafri. The network helps show where Gal Cafri may publish in the future.

Co-authorship network of co-authors of Gal Cafri

This figure shows the co-authorship network connecting the top 25 collaborators of Gal Cafri. A scholar is included among the top collaborators of Gal Cafri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gal Cafri. Gal Cafri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Cafri, Gal, Sumit Chatterji, Dan Dominissini, et al.. (2022). Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens. Journal for ImmunoTherapy of Cancer. 10(5). e003733–e003733. 6 indexed citations

Levin, Noam, Biman C. Paria, Nolan R. Vale, et al.. (2021). Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy. Clinical Cancer Research. 27(18). 5084–5095. 29 indexed citations

Leko, Vid, Gal Cafri, Rami Yossef, et al.. (2021). Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma. Journal for ImmunoTherapy of Cancer. 9(7). e002882–e002882. 15 indexed citations

Cafri, Gal, Jared J. Gartner, Tal Zaks, et al.. (2020). mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer. Journal of Clinical Investigation. 130(11). 5976–5988. 313 indexed citations breakdown →

Cafri, Gal, Rami Yossef, Anna Pasetto, et al.. (2019). Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. Nature Communications. 10(1). 449–449. 112 indexed citations

Cafri, Gal, Jared J. Gartner, Kristen Hopson, et al.. (2019). Immunogenicity and tolerability of personalized mRNA vaccine mRNA-4650 encoding defined neoantigens expressed by the autologous cancer.. Journal of Clinical Oncology. 37(15_suppl). 2643–2643. 18 indexed citations

Yossef, Rami, Eric Tran, Alena Gros, et al.. (2018). Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy. JCI Insight. 3(19). 156 indexed citations

Baumann, Daniel, Gal Cafri, Esther Tzehoval, et al.. (2018). Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. OncoImmunology. 7(7). e1445457–e1445457. 15 indexed citations

Cafri, Gal, Stefan B. Eichmüller, Esther Tzehoval, et al.. (2018). A universal anti‐cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival. International Journal of Cancer. 144(4). 909–921. 7 indexed citations

10.

Levin, Noam, Gal Cafri, Galit Eisenberg, et al.. (2016). Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40. Journal of Immunotherapy. 40(2). 39–50. 10 indexed citations

11.

Cafri, Gal, Esther Tzehoval, Zoya Alteber, et al.. (2015). mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity. Molecular Therapy. 23(8). 1391–1400. 15 indexed citations

12.

Eisenberg, Galit, Arthur Machlenkin, Alon Margalit, et al.. (2015). Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells. Clinical & Experimental Immunology. 182(2). 220–229. 15 indexed citations

13.

Alteber, Zoya, et al.. (2014). Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity. Cancer Immunology Immunotherapy. 63(4). 369–380. 24 indexed citations

14.

Cafri, Gal, et al.. (2013). Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp10025–33 Peptides. PLoS ONE. 8(2). e55583–e55583. 9 indexed citations

15.

Cafri, Gal, Alon Margalit, Esther Tzehoval, Lea Eisenbach, & Gideon Gross. (2013). Development of novel genetic cancer vaccines based on membrane‐attached β₂ microglobulin. Annals of the New York Academy of Sciences. 1283(1). 87–90. 1 indexed citations

16.

Cafri, Gal, Gabriela Koifman, Sigal Fishman, et al.. (2011). Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene. International Immunology. 23(7). 453–461. 11 indexed citations

17.

Carmi, Yaron, Gal Cafri, Esther Tzehoval, et al.. (2005). Membrane-Anchored β2-Microglobulin Stabilizes a Highly Receptive State of MHC Class I Molecules. The Journal of Immunology. 174(4). 2116–2123. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact